Discusses the period when block copolymers containing PEO, hydrophilic B-blocks, and PAA or PAGA, hydrophobic A-blocks, have been widely utilised to formulate parenteral drug delivery systems for peptides and proteins, such as micro and nanoparticles, implants, micelles, hydrogels and scaffolds.